- Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage
- Cannabinoid Type 2 Receptors Mediate a Cell Type Specific Plasticity in the Hippocampus
- CB2 cannabinoid receptors as an emerging target for demyelinating diseases- from neuroimmune interactions to cell replacement strategies
- Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
- Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
- Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
- The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway
- Role of CB2 receptors in social and aggressive behavior in male mice
- The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
- Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.